Development and evaluation of decorated aceclofenac nanocrystals

Colloids Surf B Biointerfaces. 2016 Jul 1:143:206-212. doi: 10.1016/j.colsurfb.2016.03.022. Epub 2016 Mar 10.

Abstract

This study was aimed at achieving enhanced solubility of aceclofenac (ACF) in nanocrystaline forms (ACF-NC) and evaluating the effects of ACF-NC on cell viability. Decorated ACF-NC were prepared by nano-precipitation with stabilizers. Three kinds of stabilizers were investigated: Tween 80, Poloxamer 407, and PEG 6000. The crystal structure and morphology of ACF-NC were characterized by field emission scanning electron microscopy (FE-SEM) and differential scanning calorimetry (DSC). The solubility of ACF-NC and ACF (pure) was evaluated in different media (pH 1.2 and pH 6.8 buffers and distilled water [DW]). A drug release study was performed in PBS for 24h. Cell viability was evaluated for 24h using a human colon cancer cell-line (HCT-116) and a human breast cancer cell-line (MCF-7). Decorated ACF-NC with a mean size of 725nm were successfully prepared. The solubility of the decorated ACF-NC were 4-7 times higher than that of ACF in DW and pH 6.8 buffer. A peak shift from 153.1°C to 150.5-151.0°C was observed in the DSC thermogram of decorated ACF-NC versus ACF. In terms of drug release, there was an initial burst in decorated ACF-NC within 1h followed by slow release for up to 4h. Decorated ACF-NC exhibited viability approximately 63.9% of HCT-116 cells and also showed viability in 58.3% of MCF-7 cells at 15μg/mL of drug concentration. In conclusion, decorated ACF-NC proved to be a promising approach for enhancing drug solubility and cytotoxicity.

Keywords: Aceclofenac (ACF); Cell viability; Drug release; Nanocrystals (NC); Solubility.

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / chemistry
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacokinetics
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology
  • Calorimetry, Differential Scanning
  • Cell Survival / drug effects
  • Diclofenac / analogs & derivatives*
  • Diclofenac / chemistry
  • Diclofenac / pharmacology
  • Dose-Response Relationship, Drug
  • Drug Compounding / methods*
  • Drug Liberation
  • HCT116 Cells
  • Humans
  • Hydrogen-Ion Concentration
  • MCF-7 Cells
  • Microscopy, Electron, Scanning
  • Molecular Structure
  • Nanoparticles / chemistry*
  • Nanoparticles / ultrastructure
  • Particle Size
  • Poloxamer / chemistry
  • Polyethylene Glycols / chemistry
  • Polysorbates / chemistry
  • Solubility

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Polysorbates
  • Poloxamer
  • Diclofenac
  • Polyethylene Glycol 6000
  • Polyethylene Glycols
  • aceclofenac